COAPT Risk Score против ManageMR Использование & Stats

For educational purposes and for use by medical professionals only. For patients with severe functional mitral regurgitation and symptomatic heart failure (left ventricular ejection fraction between 20-50%) despite best medical therapy. The COAPT Risk Score is a simple risk prediction tool created by combining clinical and echocardiographic variables in patients with heart failure (HF) and moderate-to-severe or severe functional mitral regurgitation (FMR) who remain symptomatic despite maximally tolerated guideline directed medical therapy (GDMT). The COAPT Risk Score provides valuable prognostic information regarding the 2-year risk of death and/or heart failure hospitalization (HFH). The score is derived from the COAPT trial population of patients with HF and moderate-to-severe or severe FMR randomized to treatment with either transcatheter edge-to-edge repair (TEER) with MitraClip plus GDMT or GDMT alone. We can incorporate TEER in the risk score and provide updated 2-year risk of death and/or HFH which can serve as a valuable shared decision-making tool for patients and physicians as well as heart teams while deciding about TEER. Created by a team of subject-matter experts including: the director of The Mount Sinai Hospital cardiac cath lab Dr. Kini, Director of Clinical and Interventional Cardiology at the Mount Sinai Health System Dr Sharma, the Mount Sinai Hospital Surgical Director Dr. Tang, COAPT Principal Investigator Dr. Stone, and COAPT Risk Score publication author Dr. Shah.
  • Apple App Store
  • Бесплатный
  • Медицина

Рейтинг магазина

- -

ManageMR provides clinicians with personalized referral and treatment advice for diagnosed mitral regurgitation patients by verifying the severity and etiology of the MR. • Enter patient parameters from an echo assessment. • Review customized advice on - Probable severity and etiology of a patient’s MR - Need for referral - Feasibility of mitral valve repair vs. replacement for the patient Content in this app is derived from the 2017 ACC Expert Consensus Decision Pathway on the Management of Mitral Regurgitation. The information and advice in this app are meant to support clinical decision making. They are not meant to represent the only or best course of care, or replace clinical judgment. Therapeutic options should be determined after discussion between the patient and their care provider. ManageMR is part of the ManageMR Toolkit supported by Founding Sponsor Abbott Vascular.
  • Apple App Store
  • Бесплатный
  • Медицина

Рейтинг магазина

- -

COAPT Risk Score vs. ManageMR ranking comparison

Compare COAPT Risk Score ranking trend in the past 28 days vs. ManageMR

Rank

Нет данных

Рейтинг COAPT Risk Score против ManageMR в сравнении по странам

Сравните динамику рейтинга COAPT Risk Score за последние 28 дней с динамикой рейтинга ManageMR.

Нет данных для отображения

Сравните данные с любым сайтом, воспользовавшись бесплатной пробной версией

Начать
COAPT Risk Score VS.
ManageMR

декабрь 19, 2024